San Mateo, CA, United States of America

Ching Shwun Lin

This inventor holds 3 USPTO granted patents and 4 published patent applications. Top assignee: Cell4vet Corporation. Active years: 2015-2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ching Shwun Lin. Retrieved from https://idiyas.com/inventor/ching-shwun-lin-hh0ah19s

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 3 

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2015-2019

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Ching Shwun Lin: Innovator in Veterinary Stem Cell Research

Introduction

Ching Shwun Lin is a notable inventor based in San Mateo, CA (US). She has made significant contributions to the field of veterinary medicine through her innovative research and inventions. With a total of 3 patents, her work focuses on the application of adipose tissue-derived stem cells for treating non-human mammals.

Latest Patents

Ching Shwun Lin's latest patents include compositions and methods for making and using adipose-derived stem cells for treating various medical conditions in non-human mammals. This groundbreaking invention aims to enhance veterinary care by utilizing advanced stem cell technology.

Career Highlights

Ching Shwun Lin is currently associated with Cell4vet Corporation, where she continues to develop her research in veterinary applications of stem cells. Her work is pivotal in advancing the treatment options available for animals, showcasing her dedication to improving veterinary medicine.

Collaborations

Ching Shwun Lin collaborates with esteemed colleagues such as Tom F Lue and Guiting Lin, contributing to a dynamic research environment that fosters innovation and discovery.

Conclusion

Ching Shwun Lin's contributions to veterinary medicine through her patents and research exemplify her commitment to enhancing animal health. Her work with adipose tissue-derived stem cells represents a significant advancement in the field, promising better treatment options for non-human mammals.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…